Clinical Trial Update: Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients

View source ↗

Summary

Completed open-label tolerability and safety monitoring study of Novantrone (mitoxantrone) in a selected cohort of patients with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Novantrone (mitoxantrone)

Snippet

Sponsor: EMD Serono | Conditions: Multiple Sclerosis | Status: COMPLETED | Results posted: 2010-06-23